DUBLIN, Ireland, Jan. 24, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its 2012 financial guidance prior to the market opening on Friday, January 27, 2012.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, January 27, 2012 at 8:00 a.m. (Eastern Time) to review the guidance. To participate in the call, please dial (877) 354-4056 in the United States and Canada or (678) 809-1043 internationally.
Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events and Presentations.
A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (800) 585-8367 within the United States and Canada or (404) 537-3406 internationally. The passcode for the replay is 45430791.
The Company
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F